RHYTHM PHARMACEUTICALS INC. - COMMON STOCK

Rhythm Pharmaceuticals Announces Update to September Conference Participation

08 سبتمبر 2023 07:59:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces New ICD-10 Diagnosis Code Established for Bardet-Biedl Syndrome

06 سبتمبر 2023 07:59:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals to Present at Investor Conferences in September

28 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces Pre-Marketing Early Access Authorization for Setmelanotide for Use in Patients with Hypothalamic Obesity in France

07 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

04 أغسطس 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Update

01 أغسطس 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces Two Publications Detailing Burden of Hyperphagia and Obesity on Patients and Caregivers Living with Bardet-Biedl Syndrome

19 يوليو 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023

17 يوليو 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

13 يوليو 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Presents Data Demonstrating BMI Reduction in Patients with Hypothalamic Obesity Treated with Setmelanotide over Six Months at ENDO 2023

17 يونيو 2023 14:01:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference

07 يونيو 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

06 يونيو 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals and Genpharm Announce Collaboration to Provide IMCIVREE® (setmelanotide) to Patients in Gulf Cooperation Council Countries

22 مايو 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® Setmelanotide Injection for Weight Management in Bardet-Biedl Syndrome or Genetically-confirmed Biallelic POMC, PCSK1, or LEPR Deficiency

08 مايو 2023 08:00:08 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

05 مايو 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update

02 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Germany for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

24 أبريل 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023

18 أبريل 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference

10 أبريل 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

06 أبريل 2023 16:01:00 بحسب Nasdaq GlobeNewswire